Literature DB >> 30526332

Complications of Intravesical BCG Immunotherapy for Bladder Cancer.

Daniel B Green1, Akira Kawashima1, Christine O Menias1, Takashi Tanaka1, Gil Redelman-Sidi1, Sanjeev Bhalla1, Rakesh Shah1, Bernard F King1.   

Abstract

An earlier incorrect version appeared online. This article was corrected on December 14, 2018.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30526332     DOI： 10.1148/rg.2019180014

Source DB:  PubMed          Journal:  Radiographics        ISSN： 0271-5333            Impact factor:   5.333


  10 in total

1.  Mycobacterium bovis bacille Calmette-Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy.

Authors:  Patrick Gellings; Michelle Galeas-Pena; Lisa A Morici
Journal:  Clin Exp Med       Date:  2022-01-25       Impact factor: 3.984

2.  Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy.

Authors:  Frédéric Quatannens; Peter Matthys; Charles-Edouard Heylen
Journal:  J Belg Soc Radiol       Date:  2022-07-06       Impact factor: 1.912

3.  An uncommon cause of miliary disease: intravesical BCG immunotherapy.

Authors:  Marcelo Azevedo; Glaúcia Zanetti; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2021-10-15       Impact factor: 2.800

4.  Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer.

Authors:  Ana T Vilares; Cláudio Nunes Silva; Miguel Correia da Silva; Joel Sousa; Bárbara Viamonte; António J Madureira
Journal:  Radiol Case Rep       Date:  2022-05-06

5.  Imaging Spectrum of Granulomatous Diseases of the Abdomen and Pelvis.

Authors:  Muhammad Naeem; Christine O Menias; Austin J Cail; Maria Zulfiqar; David H Ballard; Perry J Pickhardt; David H Kim; Meghan G Lubner; Vincent M Mellnick
Journal:  Radiographics       Date:  2021-04-16       Impact factor: 5.333

6.  Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature.

Authors:  Keiichi Narita; Hirotaka Akita; Eiji Kikuchi; Tadaki Nakahara; Shigeo Okuda; Seishi Nakatsuka; Mototsugu Oya; Masahiro Jinzaki
Journal:  BJR Case Rep       Date:  2019-11-15

7.  Cell-Level Spatio-Temporal Model for a Bacillus Calmette-Guérin-Based Immunotherapy Treatment Protocol of Superficial Bladder Cancer.

Authors:  Teddy Lazebnik
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666

8.  Incidental discovery of a case of renal tuberculoma after intravesical BCG treatment.

Authors:  Komi Hola Sikpa; Philippe Danjou; Zied Mahjoubi; Samuel Makke; Agathe Bernard; Chamseddine Chaabane
Journal:  Urol Case Rep       Date:  2022-07-31

Review 9.  BCG in Bladder Cancer Immunotherapy.

Authors:  Song Jiang; Gil Redelman-Sidi
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

10.  Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer - A rare complication.

Authors:  Katherine Ong; John Dyer; Moira Wilson; Dickon Hayne
Journal:  Urol Case Rep       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.